These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26401764)

  • 21. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease.
    Snider BJ; Holtzman DM
    Neuron; 2021 Oct; 109(20):3199-3202. PubMed ID: 34525328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
    Yaffe K; Tocco M; Petersen RC; Sigler C; Burns LC; Cornelius C; Khachaturian AS; Irizarry MC; Carrillo MC
    Alzheimers Dement; 2012 May; 8(3):237-42. PubMed ID: 22546356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Alzheimer's disease: a global challenge for next generation neuroscientists.
    Rodríguez-Gómez O; Palacio-Lacambra ME; Palasí A; Ruiz-Laza A; Boada-Rovira M
    J Alzheimers Dis; 2014; 42 Suppl 4():S515-23. PubMed ID: 25351111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory processes and Alzheimer's disease.
    Walsh S; Aisen PS
    Expert Rev Neurother; 2004 Sep; 4(5):793-8. PubMed ID: 15853506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
    Quinn JF
    J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.
    Nacmias B; Bagnoli S; Piaceri I; Sorbi S
    J Alzheimers Dis; 2018; 62(3):903-911. PubMed ID: 29103034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic mouse models of brain ageing and Alzheimer's disease.
    Bilkei-Gorzo A
    Pharmacol Ther; 2014 May; 142(2):244-57. PubMed ID: 24362083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease.
    Bonner JM; Boulianne GL
    Exp Gerontol; 2011 May; 46(5):335-9. PubMed ID: 20719244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical Alzheimer's disease therapeutics.
    Rafii MS
    J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
    Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
    FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.
    Plagg B; Marksteiner J; Kniewallner KM; Humpel C
    Biogerontology; 2015 Aug; 16(4):543-58. PubMed ID: 25947203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NGF and the treatment of Alzheimer's disease.
    Olson L
    Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
    Windisch M
    Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease.
    Platt B; Welch A; Riedel G
    Biochem Soc Trans; 2011 Aug; 39(4):874-80. PubMed ID: 21787316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.